Global Glucosamine Sulfate API Market Growth 2024-2030

Publication ID:

LPI07241262

Publication Date:

July 29, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Glucosamine is a natural compound found in cartilage 鈥� the tough tissue that cushions joints. Since glucosamine has an active amino group and its chemical properties are not very stable, the glucosamine compounds commonly used on the market currently exist mainly in the form of glucosamine hydrochloride, glucosamine sulfate and their complex salts.
Glucosamine sulfate is a natural amino monosaccharide and an important component necessary for the synthesis of proteoglycans in the matrix of human articular cartilage. It can repair cartilage, promote the formation of synovial fluid, and effectively inhibit the inflammatory process.
The global Glucosamine Sulfate API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淕lucosamine Sulfate API Industry Forecast鈥� looks at past sales and reviews total world Glucosamine Sulfate API sales in 2023, providing a comprehensive analysis by region and market sector of projected Glucosamine Sulfate API sales for 2024 through 2030. With Glucosamine Sulfate API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glucosamine Sulfate API industry.
This Insight Report provides a comprehensive analysis of the global Glucosamine Sulfate API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucosamine Sulfate API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Glucosamine Sulfate API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glucosamine Sulfate API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glucosamine Sulfate API.
United States market for Glucosamine Sulfate API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Glucosamine Sulfate API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Glucosamine Sulfate API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Glucosamine Sulfate API players cover Bioiberica, Andhra Medi Pharma, Panvo Organics, TSI, Yangzhou Rixing Bio-tech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Glucosamine Sulfate API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Glucosamine Sulfate Sodium Salt
Glucosamine Sulfate Potassium Salt
Segmentation by Application:
Pharmaceutical
Health Products
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bioiberica
Andhra Medi Pharma
Panvo Organics
TSI
Yangzhou Rixing Bio-tech
Shandong Runde Biotechnology
Fujian huakang pharmaceutical
Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Jiangsu Shuanglin Marine Biological Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glucosamine Sulfate API market?
What factors are driving Glucosamine Sulfate API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glucosamine Sulfate API market opportunities vary by end market size?
How does Glucosamine Sulfate API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glucosamine Sulfate API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Glucosamine Sulfate API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Glucosamine Sulfate API by Country/Region, 2019, 2023 & 2030
2.2 Glucosamine Sulfate API Segment by Type
2.2.1 Glucosamine Sulfate Sodium Salt
2.2.2 Glucosamine Sulfate Potassium Salt
2.3 Glucosamine Sulfate API Sales by Type
2.3.1 Global Glucosamine Sulfate API Sales Market Share by Type (2019-2024)
2.3.2 Global Glucosamine Sulfate API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Glucosamine Sulfate API Sale Price by Type (2019-2024)
2.4 Glucosamine Sulfate API Segment by Application
2.4.1 Pharmaceutical
2.4.2 Health Products
2.5 Glucosamine Sulfate API Sales by Application
2.5.1 Global Glucosamine Sulfate API Sale Market Share by Application (2019-2024)
2.5.2 Global Glucosamine Sulfate API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Glucosamine Sulfate API Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Glucosamine Sulfate API Breakdown Data by Company
3.1.1 Global Glucosamine Sulfate API Annual Sales by Company (2019-2024)
3.1.2 Global Glucosamine Sulfate API Sales Market Share by Company (2019-2024)
3.2 Global Glucosamine Sulfate API Annual Revenue by Company (2019-2024)
3.2.1 Global Glucosamine Sulfate API Revenue by Company (2019-2024)
3.2.2 Global Glucosamine Sulfate API Revenue Market Share by Company (2019-2024)
3.3 Global Glucosamine Sulfate API Sale Price by Company
3.4 Key Manufacturers Glucosamine Sulfate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucosamine Sulfate API Product Location Distribution
3.4.2 Players Glucosamine Sulfate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Glucosamine Sulfate API by Geographic Region
4.1 World Historic Glucosamine Sulfate API Market Size by Geographic Region (2019-2024)
4.1.1 Global Glucosamine Sulfate API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Glucosamine Sulfate API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Glucosamine Sulfate API Market Size by Country/Region (2019-2024)
4.2.1 Global Glucosamine Sulfate API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Glucosamine Sulfate API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Glucosamine Sulfate API Sales Growth
4.4 APAC Glucosamine Sulfate API Sales Growth
4.5 Europe Glucosamine Sulfate API Sales Growth
4.6 Middle East & Africa Glucosamine Sulfate API Sales Growth
5 Americas
5.1 Americas Glucosamine Sulfate API Sales by Country
5.1.1 Americas Glucosamine Sulfate API Sales by Country (2019-2024)
5.1.2 Americas Glucosamine Sulfate API Revenue by Country (2019-2024)
5.2 Americas Glucosamine Sulfate API Sales by Type (2019-2024)
5.3 Americas Glucosamine Sulfate API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucosamine Sulfate API Sales by Region
6.1.1 APAC Glucosamine Sulfate API Sales by Region (2019-2024)
6.1.2 APAC Glucosamine Sulfate API Revenue by Region (2019-2024)
6.2 APAC Glucosamine Sulfate API Sales by Type (2019-2024)
6.3 APAC Glucosamine Sulfate API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glucosamine Sulfate API by Country
7.1.1 Europe Glucosamine Sulfate API Sales by Country (2019-2024)
7.1.2 Europe Glucosamine Sulfate API Revenue by Country (2019-2024)
7.2 Europe Glucosamine Sulfate API Sales by Type (2019-2024)
7.3 Europe Glucosamine Sulfate API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glucosamine Sulfate API by Country
8.1.1 Middle East & Africa Glucosamine Sulfate API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Glucosamine Sulfate API Revenue by Country (2019-2024)
8.2 Middle East & Africa Glucosamine Sulfate API Sales by Type (2019-2024)
8.3 Middle East & Africa Glucosamine Sulfate API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucosamine Sulfate API
10.3 Manufacturing Process Analysis of Glucosamine Sulfate API
10.4 Industry Chain Structure of Glucosamine Sulfate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucosamine Sulfate API Distributors
11.3 Glucosamine Sulfate API Customer
12 World Forecast Review for Glucosamine Sulfate API by Geographic Region
12.1 Global Glucosamine Sulfate API Market Size Forecast by Region
12.1.1 Global Glucosamine Sulfate API Forecast by Region (2025-2030)
12.1.2 Global Glucosamine Sulfate API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Glucosamine Sulfate API Forecast by Type (2025-2030)
12.7 Global Glucosamine Sulfate API Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Bioiberica
13.1.1 Bioiberica Company Information
13.1.2 Bioiberica Glucosamine Sulfate API Product Portfolios and Specifications
13.1.3 Bioiberica Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bioiberica Main Business Overview
13.1.5 Bioiberica Latest Developments
13.2 Andhra Medi Pharma
13.2.1 Andhra Medi Pharma Company Information
13.2.2 Andhra Medi Pharma Glucosamine Sulfate API Product Portfolios and Specifications
13.2.3 Andhra Medi Pharma Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Andhra Medi Pharma Main Business Overview
13.2.5 Andhra Medi Pharma Latest Developments
13.3 Panvo Organics
13.3.1 Panvo Organics Company Information
13.3.2 Panvo Organics Glucosamine Sulfate API Product Portfolios and Specifications
13.3.3 Panvo Organics Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Panvo Organics Main Business Overview
13.3.5 Panvo Organics Latest Developments
13.4 TSI
13.4.1 TSI Company Information
13.4.2 TSI Glucosamine Sulfate API Product Portfolios and Specifications
13.4.3 TSI Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 TSI Main Business Overview
13.4.5 TSI Latest Developments
13.5 Yangzhou Rixing Bio-tech
13.5.1 Yangzhou Rixing Bio-tech Company Information
13.5.2 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Product Portfolios and Specifications
13.5.3 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Yangzhou Rixing Bio-tech Main Business Overview
13.5.5 Yangzhou Rixing Bio-tech Latest Developments
13.6 Shandong Runde Biotechnology
13.6.1 Shandong Runde Biotechnology Company Information
13.6.2 Shandong Runde Biotechnology Glucosamine Sulfate API Product Portfolios and Specifications
13.6.3 Shandong Runde Biotechnology Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shandong Runde Biotechnology Main Business Overview
13.6.5 Shandong Runde Biotechnology Latest Developments
13.7 Fujian huakang pharmaceutical
13.7.1 Fujian huakang pharmaceutical Company Information
13.7.2 Fujian huakang pharmaceutical Glucosamine Sulfate API Product Portfolios and Specifications
13.7.3 Fujian huakang pharmaceutical Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fujian huakang pharmaceutical Main Business Overview
13.7.5 Fujian huakang pharmaceutical Latest Developments
13.8 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
13.8.1 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Company Information
13.8.2 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Sulfate API Product Portfolios and Specifications
13.8.3 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Main Business Overview
13.8.5 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Latest Developments
13.9 Jiangsu Shuanglin Marine Biological Pharmaceutical
13.9.1 Jiangsu Shuanglin Marine Biological Pharmaceutical Company Information
13.9.2 Jiangsu Shuanglin Marine Biological Pharmaceutical Glucosamine Sulfate API Product Portfolios and Specifications
13.9.3 Jiangsu Shuanglin Marine Biological Pharmaceutical Glucosamine Sulfate API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu Shuanglin Marine Biological Pharmaceutical Main Business Overview
13.9.5 Jiangsu Shuanglin Marine Biological Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂